U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H36N2O4.C4H4O4
Molecular Weight 508.6044
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ARTEROLANE MALEATE

SMILES

OC(=O)\C=C/C(O)=O.CC(C)(N)CNC(=O)C[C@H]1CC[C@]2(CC1)OOC3(O2)C4CC5CC(C4)CC3C5

InChI

InChIKey=SVDSPJJUJMMDFX-CXCXETQFSA-N
InChI=1S/C22H36N2O4.C4H4O4/c1-20(2,23)13-24-19(25)12-14-3-5-21(6-4-14)26-22(28-27-21)17-8-15-7-16(10-17)11-18(22)9-15;5-3(6)1-2-4(7)8/h14-18H,3-13,23H2,1-2H3,(H,24,25);1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,15?,16?,17?,18?,21+,22?;

HIDE SMILES / InChI

Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Molecular Formula C22H36N2O4
Molecular Weight 392.5322
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Arterolane is an anti-malarial drug developed by Ranbaxy Laboratories. Arterolane belongs to peroxidic antimalarial compounds. Upon administration, the drug is activated by heme of hemoglobin digested by malarial parasite. Activation produces free radicals, leading to alkylation of heme and proteins, critical for the survival of the parasite. Arterolane was approved for marketing in India in 2012 and received marketing authorization in several African countries in 2014.

Approval Year

PubMed

PubMed

TitleDatePubMed
Identification of an antimalarial synthetic trioxolane drug development candidate.
2004 Aug 19
Synthetic antimalaria drug enters clinical trials.
2004 Oct
[Artemisinin and successors].
2005
Infectious diseases. Source of new hope against malaria is in short supply.
2005 Jan 7
In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.
2006 Jul
Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
2006 Jul
In vitro susceptibility of P. falciparum populations from Colombia and Tanzania to a new synthetic peroxide (OZ277).
2007 Jun
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
2007 Mar
The future of artemisinins: natural, synthetic or recombinant?
2008 Dec 15
Characterization of the two major CYP450 metabolites of ozonide (1,2,4-trioxolane) OZ277.
2008 Mar 1
In vitro assessment of the pharmacodynamic properties of DB75, piperaquine, OZ277 and OZ401 in cultures of Plasmodium falciparum.
2008 Nov
Drug metabolism and pharmacokinetics.
2008 Oct
Simultaneous determination of OZ277, a synthetic 1,2,4-trioxolane antimalarial, and its polar metabolites in rat plasma using hydrophilic interaction chromatography.
2009 Oct 1
Comparative embryotoxicity of different antimalarial peroxides: in vitro study using the rat whole embryo culture model (WEC).
2010 Dec
Development and validation of a headspace gas chromatographic method for the determination of residual solvents in arterolane (RBx11160) maleate bulk drug.
2010 Jan
The structure-activity relationship of the antimalarial ozonide arterolane (OZ277).
2010 Jan 14
Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial.
2010 Sep 15
Substance Class Chemical
Created
by admin
on Sat Dec 16 15:04:37 GMT 2023
Edited
by admin
on Sat Dec 16 15:04:37 GMT 2023
Record UNII
1C86ZU1OEN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ARTEROLANE MALEATE
Common Name English
Arterolane maleate [WHO-DD]
Common Name English
DISPIRO(CYCLOHEXANE-1,3'-(1,2,4)TRIOXOLANE-5',2''-TRICYCLO(3.3.1.13,7)DECANE)-4-ACETAMIDE, N-(2-AMINO-2-METHYLPROPYL)-, CIS-, (2Z)-2-BUTENEDIOATE (1:1)
Systematic Name English
Code System Code Type Description
CAS
959520-73-1
Created by admin on Sat Dec 16 15:04:37 GMT 2023 , Edited by admin on Sat Dec 16 15:04:37 GMT 2023
PRIMARY
FDA UNII
1C86ZU1OEN
Created by admin on Sat Dec 16 15:04:37 GMT 2023 , Edited by admin on Sat Dec 16 15:04:37 GMT 2023
PRIMARY
SMS_ID
300000039291
Created by admin on Sat Dec 16 15:04:37 GMT 2023 , Edited by admin on Sat Dec 16 15:04:37 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY